The Latest Breaking News from Pfizer

Why Biden’s bout with COVID-19 is likely to be easier than Trump’s

Nearly two years separate the COVID-19 diagnoses of then-President Donald Trump and current President Joe Biden. In a pandemic that has engaged the full powers of the American medical and scientific establishments, that is a lifetime.

Los Angeles Times · Jul 21, 2022

What to know about Paxlovid, the COVID drug President Biden is using to speed recovery

Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.

WEKU · Jul 21, 2022

Is Buying Pfizer Stock Right Now a Mistake?

Popular pharmaceutical company Pfizer (PFE) has entered into an agreement with the U.S. government to provide more COVID-19 vaccines. However, the stock is down more than 13% this year. Hence, will it be wise to invest in the stock now? Read on to find out….

StockNews.com · Jul 21, 2022

Pfizer slapped with £63 million fine by CMA

Pharma firm Flynn was also charged £6.7 million as part of the CMA investigation

Evening Standard · Jul 21, 2022

Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug

Penalties come after an in-depth investigation carried out by the Competition and Markets Authority

The Guardian - UK · Jul 21, 2022

The morning symptom which means you should 'assume you have Covid'

A leading Covid scientist said twice as many people have coronavirus as the common cold.

Daily Record · Jul 20, 2022

Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab

Pfizer (NYSE: PFE) and its partner, BioNTech (NASDAQ: BNTX) announced that they have completed the submission of a regulatory application to the European Medicines Agency (EMA), which seeks authorization for thei

Benzinga · Jul 20, 2022

The morning symptom which means you should 'assume you have covid'

Twice as many people currently have covid as have the common cold as cases rocket

Wales Online · Jul 20, 2022

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.

WEKU · Jul 20, 2022

Novavax COVID shot for adults gains CDC advisers’ backing

Novavax Inc.’s shares surged after its COVID-19 vaccine won backing from a panel of U.S. public health advisers, a crucial step in providing officials with another tool against the virus as cases start to rise again.

Tribune News Service · Jul 19, 2022